Novo Nordisk joined the many pharmaceutical companies pushing back on government-negotiated drug pricing in the United States.

The Federal Trade Commission put on hold a lawsuit against pharmacy-benefit manager (PBM) units of UnitedHealth , Cigna and ...

The U.S. Federal Trade Commission's lawsuit against pharmacy benefit managers over insulin pricing practices will likely move ...

As the obesity rate among people with type 1 diabetes rises, patients are taking popular weight loss drugs like Ozempic—and ...

Discover which herbs can naturally help regulate blood sugar levels. Learn which herbs work like insulin and how to safely ...

The Federal Trade Commission late Tuesday stayed a lawsuit accusing pharmacy middlemen of gaming the system to inflate the ...

Created in 1914, the FTC is tasked with stopping unfair trade practices — particularly those by big corporations that use ...

The Affordable Insulin Now Act, as it is known ... Unfortunately, the current drug pricing bill fails to take a holistic approach to addressing a system that drives affordability challenges ...

FILE PHOTO: A screen displays the logo fro Cigna Corp. on the floor at the NYSE in New York ...

The FTC lawsuit accuses the PBMs of unfairly limiting access to insulin drugs with lower list prices and steering diabetes patients towards higher priced insulin in order to reap millions of ...

The FTC in September sued the three companies, which it says together administer 80% of all prescriptions in the U.S., accusing them of unfairly limiting access to insulin drugs with lower list ...